Nutritional therapy plays a significant role in managing inflammatory bowel disease (IBD), but it is often overlooked in traditional medical care. Exclusive Enteral nutrition is effective in inducing remission, while therapeutic diets like the IBD-Anti-Inflammatory Diet and the Specific Carbohydrate Diet have shown positive results. Monitoring nutrient deficiencies and biometric measurements like grip strength are essential for optimal management of IBD. To help develop a framework for this topic I welcomed on the Kim Beall, Pharm.D., who is the Cofounder and Managing Director of Nutritional Therapy for IBD, http://www.nutritionaltherapyforibd.org a non-profit dedicated to establishing evidence-based nutritional therapy as a foundational part of IBD care to improve the well-being and health outcomes of those living with Crohnβs disease and ulcerative colitis. Kim and I met related to a mutual colleague the late Trina Seligman, ND who had a courageous life long battle with Crohns/Colitis . We share a strong bond with Trina. Here are some of the timestamps of the conversations.
00:00 - ποΈ Introduction to the One Thing Podcast and the guest, Kim Beall, Pharm.D, who is a pharmacist and the co-founder of Nutritional Therapy for IBD, a nonprofit dedicated to incorporating evidence-based nutrition into IBD care.
02:45 - π Discussion about the passing of Dr. Trina Seligman, a mentor and advocate for IBD patients, and her impact on the IBD community.
05:23 - π₯ The importance of nutrition in managing IBD and the role of exclusive enteral nutrition (EEN) in inducing remission and mucosal healing.
08:32 - π‘ Dr. Beall's personal journey with IBD and her son's diagnosis with Crohn's disease, which led her to advocate for nutrition as a foundational part of IBD care.
12:15 - π€ The need for earlier intervention and education on nutrition for IBD patients and the importance of collaboration between patients and healthcare providers.
16:10 - π€ The confusion surrounding dietary recommendations for IBD and the lack of official guidelines, leading to the need for ongoing research and evidence-based approaches.
19:05 - βοΈ The importance of avoiding blame and shame when discussing the role of diet in IBD and the complexity of factors contributing to the development of the disease.
21:20 - π The significance of biometric evaluations, such as grip strength and body mass, in assessing nutritional status and overall health in IBD patients.
24:20 - π± The current evidence for routine nutrient monitoring in IBD patients, including the importance of micronutrients like zinc, magnesium, and vitamins.
27:10 - π½οΈ The different dietary strategies and therapeutic diets for IBD, including exclusive enteral nutrition, the anti-inflammatory diet, autoimmune protocol, and specific carbohydrate diet.
32:00 - π Ongoing research on the microbiome and its potential role in IBD management, along with the need for personalized nutrition approaches based on an individual's microbiome and metabolic profile.
35:05 - πͺ The potential benefits of partial enteral nutrition and its underutilization in IBD care, including its role in maintaining remission and reducing surgical recurrence.
38:40 - π The importance of raising awareness about the efficacy of nutritional therapy in IBD and advocating for insurance coverage of nutrition-related treatments.
Key insights:
- π‘ Exclusive enteral nutrition is a highly effective therapy for inducing remission in IBD, but its use is limited in the United States. More awareness and access are needed to benefit patients.
- π‘ Monitoring nutrient deficiencies and biometric measurements like grip strength can help identify malnutrition and sarcopenia in IBD patients, leading to improved outcomes and quality of life.
- π‘ Therapeutic diets like the IBD-Anti-Inflammatory Diet and the Specific Carbohydrate Diet have shown positive results in managing both Crohn's disease and ulcerative colitis. These diets should be considered as part of a personalized treatment plan.
- π‘ The microbiome is a crucial factor in IBD, and ongoing research is exploring ways to manipulate it through diet for better disease management. Early interventions and personalized nutrition based on microbiome analysis hold promise for the future.